Product Reports Resources Pricing Login Book a demo

Ophelia

Biotech & Life Sciences · Philadelphia, United States · Founded 1994

Ophelia is a healthcare startup focused on providing medication-assisted treatment (MAT) for individuals struggling with opioid dependence. The company operates in the healthcare sector, specifically targeting patients who are experiencing cravings or withdrawal symptoms related to opioid use. Ophelia's business model revolves around offering scientifically-backed treatments that replace traditional rehab methods with a more modern, private, and convenient approach. The company makes money by providing these medical services directly to patients, leveraging a team of doctors, scientists, and tech experts to deliver high-quality care. Ophelia's mission is to eliminate the stigma associated with drug rehab by offering a discreet and effective alternative that empowers patients to make their own choices. The company serves a diverse clientele, primarily focusing on individuals under the age of 50, who are at the highest risk of opioid overdose. By combining medical expertise with a patient-centric approach, Ophelia aims to revolutionize the way opioid dependence is treated in the United States. Keywords: opioid dependence, medication-assisted treatment, healthcare startup, opioid cravings, withdrawal symptoms, patient-centric, privacy, convenience, scientific treatment, modern rehab.

Valuation $100–500M
Revenue $10–50M
Headcount 100–500
Total funding $50–100M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Ophelia and the history behind them.

Investors

13 investors on Ophelia's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage
Series A 10 investors entered at this stage
Menlo Ventures
Bloom Institute of Technology
Warby Parker
Harry's
PillPack
Smartbird | formerly Allbirds
Carbon Health
Tiger Global
Interplay
640 Oxford Ventures

Global footprint

Where Ophelia has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States98.3%
🇲🇦 Morocco0.8%
🇬🇧 United Kingdom0.8%
3 countries shown

Talent graph

The shape of Ophelia's talent

Dealroom maps Ophelia's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

10 team members profilednamed & role-tagged by Dealroom
374 employeestotal headcount
2 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Ophelia's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Ophelia

An AI-synthesized read of the highest-engagement posts about Ophelia on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ophelia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.